PPT-Endovascular Therapy for Acute Ischemic Stroke

ML006 Rev01 Adapted from Goyal Hill Demchuk ESCAPE ISC 2015 Recent Anterior Circulation Trials Low ASPECTS good ASPECTS Poor collaterals good collaterals. ML006 Rev01. Adapted from . Goyal. , Hill, . Demchuk. – ESCAPE, ISC 2015. Recent Anterior Circulation Trials. Low ASPECTS good ASPECTS. Poor collaterals good collaterals. Clinical . Director of Endovascular Surgical Neuroradiology, . Neurocritical. care and Clinical Neuroscience Research, . Valley . Baptist Medical Center. Assistant professor, Neurology and Radiology . : . A New Path for Treatment of Endothelial Dysfunction and CVD. A Webinar Presentation on December 8. th. , 2016 2PM PST. Robert A. Kloner MD, PhD. Director of the Cardiovascular Research Institute of HMRI. Children. A Brief . Overview . Tammy . Hennika. , M.D.. Childhood stroke activations. What neuroimaging?. What labs?. What is the treatment? . Can we give . tPA. ?. If not a stroke, what could it be? . Medical Director. IU Health Methodist Hospital. Comprehensive Stroke Center. Disclosures. None. Stroke Statistics. Heart Disease and Stroke Statistics 2014. ~795,000 new or recurrent strokes/year. 87% Ischemic, 10% ICH, 3% SAH. Alexandra Czap MD. 1. , Jose-Miguel Yamal PhD. 2. , Noopur Singh MPH. 2. , Stephanie Parker RN. 1. , . Suja. . S. Rajan. PhD. 3. , . Ritvij. . Bowry. MD. 1. , James . Grotta. MD. 4. Department of Neurology, 2. Department of Biostatistics and Data Science, 3. Department of Management, Policy and Community Health . Endovascular Intervention. Syed F Ali. Chief Resident, PGY3. Neurology, UAMS. . Saving lives, one clot at a time… . Add your first bullet point here. Add your second bullet point here. Add your third bullet point here. Current Status and Future Directions. Tudor G. Jovin, M.D.. Associate Professor of Neurology and Neurosurgery. Director, UPMC Stroke Institute . Director, UPMC Center for Neuroendovascular Therapy. University of Pittsburgh Medical Center . : . New . Agents, New Approaches . Andria L. Ford, . MD. Associate . Professor. Department of Neurology. Division of Cerebrovascular . Diseases. Disclosures. Research Support: . NIH . NHLBI . R01HL129241. 96 MR CLEAN (n=196)ESCAPE* (n=156)SWIFT PRIME (n=83)EXTEND-IA (n=29)REVASCAT (n=102)27 (13.8)6 (3.9)4 (4.8)1 (3)8 (7.8)11 (5.6)3 (1.9)1 (1.2)1 (3)2 (2.0)43 (21.9)34 (21.8)5 (6.0)2 (7)25 (24.5)68 (34.7 OBJECTIVE. นักศึกษาแพทย์ทราบแนวทางการประเมินและวินิจฉัยผู้ป่วยโรคหลอดเลือดสมองเบื้องต้นได้. Assist.Lect. . . Shaymaa. . Hasan. Abbas. DESIRED TREATMENT OUTCOMES. The short-term goals of treatment for acute ischemic stroke include reducing secondary brain damage by re-establishing and maintaining adequate perfusion to marginally ischemic areas of the brain and to protect these areas from the effects of ischemia (i.e., . Content. : Archana Hinduja, MD; M . Sohel. Ahmed, MD. Slides. : Archana Hinduja, MD; M . Sohel. Ahmed, MD. Editors’ Note: Global Considerations. The intent of the editors, authors, and reviewers of this ENLS topic was not to address all the variations in international practice for the different diseases. We have discussed major practice variances (e.g., the availability of diagnostic testing, or the type of medications used) and encourage learners to use the ENLS algorithms as a framework on which any relevant local practice guidelines can be incorporated.. Current and Future. Published in journal of European neurology. On august 2022. INTRODUCTION. Despite progress in the . understanding of the pathophysiological mechanisms underlying stroke over the past 3 decades, concerning early diagnosis and the development of protocols that have reduced the door-to-needle time for acute ischemic stroke (AIS) treatment, several clinical gaps remain unsolved..